Somatic mutations of mitochondrial genome in hepatocellular carcinoma

Mitochondrion

Volumn 10, Issue 2, 2010, Pages 174-182

  Yin, Pen Hui ^a   Wu, Cheng Chung ^b   Lin, Jin Ching ^b   Chi, Chin Wen ^a,c   Wei, Yau Huei ^c,d   Lee, Hsin Chen ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

HCC; Mitochondrial dysfunction; mtDNA; Somatic mutation

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; TRANSFER RNA;

AMINO ACID SUBSTITUTION; ARTICLE; BASE PAIRING; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE DELETION; GENETIC ASSOCIATION; GENETIC CODE; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MITOCHONDRIAL GENE; MITOCHONDRIAL GENOME; OXIDATIVE PHOSPHORYLATION; PHARMACOGENETICS; PRIORITY JOURNAL; SOMATIC MUTATION; STOP CODON;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CODON, NONSENSE; DNA, MITOCHONDRIAL; FRAMESHIFT MUTATION; GENOME, MITOCHONDRIAL; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; POINT MUTATION; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 76349101416     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2009.12.147     Document Type: Article

References (30)

1. Anderson S., Bankier A.T., Barrell B.G., De Bruijn M.H.L., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J.H., Staden R., and Young I.G. Sequence and organization of the human mitochondrial genome. Nature 290 (1981) 457-465
2. Blakely E.L., Poulton J., Pike M., Wojnarowska F., Turnbull D.M., McFarland R., and Taylor R.W. Childhood neurological presentation of a novel mitochondrial tRNA(Val) gene mutation. J. Neurol. Sci. 225 (2004) 99-103
3. Brandon M., Baldi P., and Wallace D.C. Mitochondrial mutations in cancer. Oncogene 25 (2006) 4647-4662
4. Chang C.J., Yin P.H., Yang D.M., Wang C.H., Hung W.Y., Chi C.W., Wei Y.H., and Lee H.C. Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells. Cell. Mol. Life Sci. 66 (2009) 1755-1765
5. Chatterjee A., Mambo E., and Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 25 (2006) 4663-4674
6. Croteau D.L., and Bohr V.A. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J. Biol. Chem. 272 (1997) 25409-25412
7. Finnila S., Tuisku S., Herva R., and Majamaa K. A novel mitochondrial DNA mutation and a mutation in the Notch3 gene in a patient with myopathy and CADASIL. J. Mol. Med. 79 (2001) 641-647
8. Hung W.Y., Lin J.C., Lee L.M., Wu C.W., Tseng L.M., Yin P.H., Chi C.W., and Lee H.C. Tandem duplication/triplication correlated with poly-cytosine stretch variation in human mitochondrial DNA D-loop region. Mutagenesis 23 (2008) 137-142
9. Hung W.Y., Wu C.W., Yin P.H., Chang C.J., Li A.F., Chi C.W., Wei Y.H., and Lee H.C. Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. Biochim. Biophys. Acta (2009) 10.1016/j.bbagen.2009.06.006
10. Jeronimo C., Nomoto S., Caballero O.L., Usadel H., Henrique R., Varzim G., Oliveira J., Lopes C., Fliss M.S., and Sidransky D. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20 (2001) 5195-5198
11. Kawanishi S., Hiraku Y., Pinlaor S., and Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 387 (2006) 365-372
12. Klaunig J.E., and Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 239-267
13. Lee H.C., and Wei Y.H. Mitochondrial DNA instability and metabolic shift in human cancers. Int. J. Mol. Sci. 10 (2009) 674-701
14. Lee H.C., Li S.H., Lin J.C., Wu C.C., Yeh D.C., and Wei Y.H. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat. Res. 547 (2004) 71-78
15. Lee H.C., Yin P.H., Lin J.C., Wu C.C., Chen C.Y., Wu C.W., Chi C.W., Tam T.N., and Wei Y.H. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann. NY Acad. Sci. 1042 (2005) 109-122
16. Lee H.J., Su Y., Lui W.Y., Chau G.Y., Yin P.H., Lee H.C., and Chi C.W. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha upregulated E-cadherin expression in HepG2 cells. FEBS Lett. 528 (2008) 627-634
17. Levin B.C., Cheng H., and Reeder D.J. A human mitochondrial DNA standard reference material for quality control in forensic identification, medical diagnosis, and mutation detection. Genomics 55 (1999) 135-146
18. Li C.H., Tzeng S.L., Cheng Y.W., and Kang J.J. Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway. J. Biol. Chem. 280 (2005) 26193-26199
19. Maynard S., Schurman S.H., Harboe C., de Souza-Pinto N.C., and Bohr V.A. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 30 (2009) 2-10
20. Mayr J.A., Meierhofer D., Zimmermann F., Feichtinger R., Kogler C., Ratschek M., Schmeller N., Sperl W., and Kofler B. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin. Cancer Res. 14 (2008) 2270-2275
21. Ala mutation is pathogenic and causes a phenotype of pure myopathy. Neuromuscul. Disord. 18 (2008) 63-67
22. Park S.Y., Chang I., Kim J.Y., Kang S.W., Park S.H., Singh K., and Lee M.S. Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase. J. Biol. Chem. 279 (2004) 7512-7520
23. Park J.S., Sharma L.K., Li H.Z., Xiang R., Holstein D., Wu J., Lechleiter J., Naylor S.L., Deng J., Lu J., and Bai Y. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum. Mol. Genet. 18 (2009) 1578-1589
24. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., Trush M.A., Kinzler K.W., and Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 20 (1998) 291-293
25. Schütte K., Bornschein J., and Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig. Dis. 27 (2009) 80-92
26. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
27. Wang X.W., Hussain S.P., Huo T.I., Wu C.G., Forgues M., Hofseth L.J., Brechot C., and Harris C.C. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 181-182 (2002) 43-47
28. Warburg O. The Metabolism of Tumors (1930), Arnold Constable, London pp. 254-270
29. Yin P.H., Lee H.C., Chau G.Y., Wu Y.T., Li S.H., Lui W.Y., Wei Y.H., Liu T.Y., and Chi C.W. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Brit. J. Cancer 90 (2004) 2390-2396
30. Yuen M.F., Hou J.L., Chutaputti A., and Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma. Hepatocellular carcinoma in the Asia Pacific region. J. Gastroenterol. Hepatol. 24 (2009) 346-353